*NEW* - A Precision Medicine Approach to Tuberculosis: Genomic Predictors of Disease Susceptibility and Treatment Adverse Reactions
12 November 2026
Main Applicant – Dr Lim Xin Rong, Senior Consultant, Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital
TB remains a significant public health concern in Singapore, with notable ethnic disparities — Malays have the highest rates of active TB despite lower rates of latent infection, suggesting underlying differences in host susceptibility or immune response. While standard first-line treatment is effective, it can cause serious adverse reactions such as liver injury and severe allergic responses, driven by immune and drug metabolism mechanisms. Although genetic variants linked to both TB susceptibility and drug toxicity have been identified in other populations, these remain poorly understood in Singapore's multi-ethnic context, and no local genomic risk tool currently exists to guide prevention or prescribing.
